HEART FAILURE, SYSTOLIC

Clinical trials for HEART FAILURE, SYSTOLIC explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE, SYSTOLIC trials appear

Sign up with your email to follow new studies for HEART FAILURE, SYSTOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 3 Completed 4 Terminated 2

New heart failure drug enters first human safety trial

Disease control Not yet recruiting

This early-stage trial will test a single dose of a new drug called LY3971297 in 90 people with two types of heart failure: preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). The main goal is to see if the drug is safe and what side effects occur. Particip…

Matched conditions: HEART FAILURE, SYSTOLIC

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

HEART FAILURE, SYSTOLIC

Get alerted when new HEART FAILURE, SYSTOLIC trials appear

New heart failure drug enters first human safety trial